AR088198A1 - Sal cristalina de clorhidrato de (1-(4-fluorofenil)-1h-indol-5-il)-(3-(4-(tiazol-2-carbonil)piperazin-1-il)azetidin-1-il)metanona - Google Patents

Sal cristalina de clorhidrato de (1-(4-fluorofenil)-1h-indol-5-il)-(3-(4-(tiazol-2-carbonil)piperazin-1-il)azetidin-1-il)metanona

Info

Publication number
AR088198A1
AR088198A1 ARP120103634A ARP120103634A AR088198A1 AR 088198 A1 AR088198 A1 AR 088198A1 AR P120103634 A ARP120103634 A AR P120103634A AR P120103634 A ARP120103634 A AR P120103634A AR 088198 A1 AR088198 A1 AR 088198A1
Authority
AR
Argentina
Prior art keywords
salt
piperazin
indol
fluorophenil
carbonil
Prior art date
Application number
ARP120103634A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR088198A1 publication Critical patent/AR088198A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a una sal cristalina de clorhidrato de (1-(4-fluorofenilo)-1H-indol-5-il)-(3-(4-(tiazol-2-carbonil)piperazin-1-il)azetidin-1-il)metanona, métodos para preparar dicha sal, composiciones farmacéuticas que contienen dicha sal, y el uso de dicha sal en el tratamiento del dolor y trastornos que dan origen a dicho dolor, y trastornos metabólicos tales como obesidad, hiperfagia y diabetes. Reivindicación 1: Una sal cristalina de clorhidrato del compuesto de fórmula (1).
ARP120103634A 2011-09-30 2012-09-28 Sal cristalina de clorhidrato de (1-(4-fluorofenil)-1h-indol-5-il)-(3-(4-(tiazol-2-carbonil)piperazin-1-il)azetidin-1-il)metanona AR088198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161541281P 2011-09-30 2011-09-30

Publications (1)

Publication Number Publication Date
AR088198A1 true AR088198A1 (es) 2014-05-14

Family

ID=47046853

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103634A AR088198A1 (es) 2011-09-30 2012-09-28 Sal cristalina de clorhidrato de (1-(4-fluorofenil)-1h-indol-5-il)-(3-(4-(tiazol-2-carbonil)piperazin-1-il)azetidin-1-il)metanona

Country Status (11)

Country Link
US (1) US8835417B2 (es)
EP (1) EP2760861A1 (es)
JP (1) JP2014528427A (es)
KR (1) KR20140072897A (es)
CN (1) CN104271573A (es)
AR (1) AR088198A1 (es)
CA (1) CA2849779A1 (es)
IN (1) IN2014DN02984A (es)
MX (1) MX342140B (es)
TW (1) TW201329073A (es)
WO (1) WO2013049287A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US4337341A (en) * 1976-11-02 1982-06-29 Eli Lilly And Company 4a-Aryl-octahydro-1H-2-pyrindines
US8106208B2 (en) * 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
CN102459255A (zh) * 2009-04-22 2012-05-16 詹森药业有限公司 作为单酰甘油脂肪酶抑制剂的氮杂环丁烷基二酰胺

Also Published As

Publication number Publication date
US20130085279A1 (en) 2013-04-04
CN104271573A (zh) 2015-01-07
WO2013049287A1 (en) 2013-04-04
US8835417B2 (en) 2014-09-16
TW201329073A (zh) 2013-07-16
KR20140072897A (ko) 2014-06-13
EP2760861A1 (en) 2014-08-06
CA2849779A1 (en) 2013-04-04
JP2014528427A (ja) 2014-10-27
IN2014DN02984A (es) 2015-05-15
MX2014003898A (es) 2014-12-05
MX342140B (es) 2016-09-14

Similar Documents

Publication Publication Date Title
BR112012023021A2 (pt) compostos de indazol e seus usos
BR112016000909A8 (pt) derivados piperidinil indólicos, seus usos, e combinação e composição farmacêuticas
EA201492050A1 (ru) Модуляторы ядерного транспорта и их применение
EA201590748A1 (ru) Противовирусные соединения против rsv
EA201590450A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
BR112016009630A8 (pt) receptores de farnesoide x, seus usos, composição farmacêutica, e combinação
EA201491329A1 (ru) 4,4-дизамещенные 1,4-дигидропиримидины и их применение в качестве лекарственных препаратов для лечения гепатита b
EA201591195A1 (ru) Новые хинолоновые производные
IN2014MN02380A (es)
CL2012003211A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso para preparar los compuestos; composicion farmaceutica que comprende a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento o prevencion de diabetes tipo 2, obesidad y condiciones relacionadas
EA201490287A1 (ru) Новые замещенные производные индола в качестве модуляторов гамма-секретазы
EA201400553A1 (ru) Производные 2-(1,2,3-триазол-2-ил)бензамида и 3-(1,2,3-триазол-2-ил)пиколинамида
NZ703989A (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
DK2121691T3 (da) Spirocykliske cyklohexanderivater
EA201100161A1 (ru) Производные хинуклидина карбоната и их медицинские композиции
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
NZ605827A (en) Co-crystals and salts of ccr3-inhibitors
PE20150709A1 (es) Benzamidas
MX2014004858A (es) Compuestos de 3,4-diamino-3-ciclobuten-1,2-diona disustituidos utiles en el tratamiento de patologias mediadas por quimiocinas.
MX342924B (es) Nuevos compuestos disustituidos de 3,4-diamino-3-ciclobuteno-1,2-d iona para uso en el tratamiento de patologias mediadas por quimiocinas.
UY33278A (es) Pirimidinas sustituidas como antagonistas del receptor de la protaglandina d2
CO6361993A2 (es) Compuestos de 4-[2-(2-fluorofenoximetil)fenil]piperidina
EA201391797A1 (ru) 3-спироциклические пиперидиновые производные в качестве агонистов грелиновых рецепторов
EA201400064A1 (ru) Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
AR084832A1 (es) Derivado cristalino de oxazina

Legal Events

Date Code Title Description
FB Suspension of granting procedure